Adaptimmune Therapeutics PLC — Director's Dealing 2016

Jan 4, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adaptimmune Therapeutics PLC (ADAP)
CIK: 0001621227
Period of Report: 2016-01-01

Reporting Person: Binder-Scholl Gwendolyn Knowlton (EVP, Adaptimmune LLC)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to purchase Ordinary Shares	$0.1736	2021-03-01	Ordinary Shares (300000)		Direct
Option to purchase Ordinary Shares	$0.1671	2023-01-01	Ordinary Shares (200000)		Direct
Option to purchase Ordinary Shares	$0.1671	2024-04-15	Ordinary Shares (500000)		Direct
Option to purchase Ordinary Shares	$0.5308	2024-12-19	Ordinary Shares (1000000)		Direct

Footnotes

F1: Curently exercisable as to 300,000 Ordinary Shares.

F2: Currently exercisable as to 150,000 Ordinary Shares and will be exercisable as to 50,000 Ordinary Shares on January 1, 2017.

F3: Exercisable as to 125,000 Ordinary Shares on April 15, 2015 and exercisable as to the remainder ratably in annual installments on the fifteenth of April from April 15, 2016 through April 15, 2018.

F4: Exercisable as to 250,000 Ordinary Shares on December 19, 2015 and will be exercisable as to the remainder in monthly installments of 20,800 Ordinary Shares on the nineteenth of each month from January 19, 2016 through November 19, 2018, and in one installment of 22,000 Ordinary Shares on December 19, 2018.

F5: The exercise price was converted from GBP0.1163 based on the noon buying rate of the Federal Reserve Bank of New York for the U.S. dollar on the date of grant. The actual exercise price will be the pounds sterling amount regardless of the exchange rate on the date of grant or of exercise.

F6: The exercise price was converted from GBP0.112 based on the noon buying rate of the Federal Reserve Bank of New York for the U.S. dollar on the date of grant. The actual exercise price will be the pounds sterling amount regardless of the exchange rate on the date of grant or of exercise.

F7: The exercise price was converted from GBP0.112 based on the noon buying rate of the Federal Reserve Bank of New York for the U.S. dollar on the date of grant. The actual exercise price will be the pounds sterling amount regardless of the exchange rate on the date of grant or of exercise.

F8: The exercise price was converted from GBP0.3557 based on the noon buying rate of the Federal Reserve Bank of New York for the U.S. dollar on the date of grant. The actual exercise price will be the pounds sterling amount regardless of the exchange rate on the date of grant or of exercise.